Clinical Trial Update: Clinicopathological Parameters of HER2 Low Breast Cancers

View source ↗

Summary

This completed clinical trial from Vardhman Mahavir Medical College and Safdarjung Hospital examined clinicopathological parameters of HER2-low breast cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Vardhman Mahavir Medical College And Safdarjung Hospital | Conditions: HER2 Low Breast Cancers | Status: COMPLETED